Bio Vitos Pharma AB (publ) (STO:BIOVIT)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1200
-0.0050 (-4.00%)
Inactive · Last trade price on Apr 11, 2025

Bio Vitos Pharma AB Company Description

Bio Vitos Pharma AB (publ) operates as a medical technology company in Sweden and internationally.

The company develops and commercializes Helge, which detects hemolysis in vacuum tubes and blood gas samples.

It serves emergency departments in the European Union and the United States. It has a collaboration agreement with KFUM Kalmar to conduct a research study.

The company was formerly known as Hemcheck Sweden AB (publ) and changed its name to Bio Vitos Pharma AB (publ) in December 2023.

Bio Vitos Pharma AB (publ) was incorporated in 2010 and is based in Solna, Sweden.

Bio Vitos Pharma AB (publ)
Country Sweden
Founded 2010
Industry Surgical and Medical Instruments and Apparatus
Employees 1
CEO Jesper Birgemo

Contact Details

Address:
Nanna Svartz väg 4
Solna, 171 65
Sweden
Phone 46 5 42 02 22 11
Website biovitospharma.com

Stock Details

Ticker Symbol BIOVIT
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
SIC Code 3841

Key Executives

Name Position
Jesper Birgemo Chief Executive Officer